Ocular Therapeutix™ To Report Fourth Quarter and Year-End 2019 Financial Results

BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report fourth quarter ended and year-ended December 31, 2019 financial results on Thursday, March 12, 2020. Following distribution of the earnings release via wire services, the Ocular Therapeutix management team will host a live conference

Full Story →